Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Cell Culture Media market is a dynamic sector characterized by various factors influencing its growth and evolution. Understanding the market dynamics is crucial for stakeholders, as it helps navigate the competitive landscape and make informed decisions.
The major market driving force here is the growing biopharmaceutical sector, where cell culture media has substantial importance for manufacturing of therapeutic proteins and vaccines. The increase in demand for biologics and biosimilars increases the need to develop more sophisticated cell culture media formulations.
Gradual development of cell culture media formulations continuously fosters market growth. There are also certain innovations, such as serum-free and chemically defined media that can help address issues of contamination or batch-to-batch variability.
Scientific research and development of cell-based therapies along with regenerative technologies boost the need for specialized cell culture media. This is especially so as scientists delve into new approaches to disease therapy and personalized medicine.
The increase in the number of biotechnology startups and academic research initiatives affects market dynamics. these entities contribute to the need of cost effective and efficient cell culture media solutions, creating a very diverse environment with different specificities.
Market dynamics are also influenced by stringent regulatory frameworks that govern the production and use of cell culture media. Market players must comply with quality standards and regulatory guidelines to ensure product approval for the market as well acceptance.
The development of biopharmaceutical manufacturing spans the globe, which gives rise to a worldwide need for standardized and high-quality cell culture medium. Market players should adapt to regional differences and preferences in order to gain a solid position on the world stage.
Market dynamics are still influenced by cost considerations. Given the increasing need for cell culture media worldwide, there is also a demand out there to develop affordable solutions especially in emerging markets where low budget may restrict consumption of high-priced formulations.
he competition in the market is high and this pushes companies into strategic alliances or partnerships. Mergers, acquisitions, and partnerships are very vital in the relationships of market dynamics because through them companies can be able to reinforce their product offerings as well as reach larger markets.
There is a significant trend towards animal component-free cell culture media in the industry. This drift is a reaction to the issues of ethics, reducing potential contamination possibilities and requirements from users who need precise and repeatable formulations in their media.
The COVID-19 pandemic has underscored the importance of the cell culture media market, particularly in the context of vaccine development and production. The surge in vaccine research and production activities has heightened the demand for specialized media formulations, impacting market dynamics significantly.
Cell Culture Media Market Highlights:
Global Cell Culture Media Market Overview
Cell Culture Media Market size was valued at USD 3.85 billion in 2023. The Cell Culture Media Market industry is projected to grow from USD 4.39 billion in 2024 to USD 12.47 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13.92% during the forecast period (2024 - 2032).
The growth of the cell culture media market is attributed to the strategic initiatives to boost pharmaceutical R&D, cell culture media associated product launch & investment, and the increasing incidences of chronic diseases.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Cell Culture Media Trends
- Increasing incidences of chronic diseases fuels market growth
The rising prevalence of chronic diseases is increasing the demand for pharmaceutical products, which further increases the demand for cell culture media. As per the GLOBOCAN 2020, Asia accounted for the largest share (49.5%), followed by Europe (22.8%), North America (13.3%), Latin America and the Caribbean (7.6%), Africa (5.7%), and Oceania (1.3%). Moreover, according to the World Health Organization, approximately 50 million people diagnosed with epilepsy by February 2024, globally, which is the most common neurological disease across the globe. Furthermore, the Diabetes Atlas 2021 reported that the Western Pacific had 206 million, followed by Southeast Asia with 90 million, the Middle East and North Africa with 73 million, Europe with 61 million, North America and the Caribbean with 51 million, South and Central America with 32 million, and Africa with 24 million people with diabetes. Therefore, the high incidence of the above-mentioned diseases increases the demand for innovative drugs, which certainly leads to the R&D of products for such diseases, boosting the cell culture media market.
Cell Culture Media Segment Insights
Cell Culture Media Product Type Insights
The Cell culture supplements Market segmentation, based on product type, includes media and supplements. The media segment held the majority share in the market in 2022. The media segment is further sub-segmented into basal media, complex media, and serum-free while the supplements segment is sub-segmented into fetal bovine serum (FBS), newborn calf serum, horse serum, and others. Cell culture media generally comprise an appropriate source of energy and compounds which regulate the cell cycle. Stem cell culture is used for stem cell research and drug discovery processes that include cancer research, drug testing and development, and regenerative and cell-based therapies. Serum-Free Media (SFM) helps researchers to grow a specific cell type in the culture media. The presence of serum in the media sometimes misinterprets in immunological studies. These media are specifically formulated to boost the culture of a single cell type, such as knockout Dulbecco's Modified Eagle Medium (DMEM) and knockout serum replacement. It is also used in the production of monoclonal antibodies (MAbs). Thermo Fisher Scientific provides HyClone Products, such as CCM1q, PF-MAbq, and SFX-MAbq. CCM1 is serum-free media product in the market.
Cell Culture Media Application Insights
The Cell Culture Media Market segmentation, based on application, includes regenerative medicine, biopharmaceutical production, and research. The biopharmaceutical production segment dominated the market in 2022. Biopharmaceutical production is the production of biologics-based therapeutic drugs, including protein-based therapeutics, vaccines, gene therapies, and cell therapies. Cell cultures form the base for the Biopharmaceutical production of many large molecule-based drugs, vaccines, and cellular therapies where cell culture media is used.
Figure 2: Cell Culture Media Market, by Application, 2024 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Cell Culture Media Cell Type Insights
The Cell Culture Media Market segmentation, based on cell type, includes animal cells, plant cells, and bacterial cells. The bacterial cells segment dominated the market in 2022. The bacterial cultures are used for recombinant protein expression, plasmid cloning and amplification, and bacterial artificial chromosome (BAC) and cosmid cloning. Bacterial cells can be altered to uptake and incorporate exogenous genes and plasmids through transformation.
Cell Culture Media Regional Insights
By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. The North America cell culture suppliments market accounted for the largest market share in 2022. North America is attributed to the presence of major manufacturers, the increasing prevalence of diseases leading to the high demand for drugs and other medications, technological advancements in the preclinical and clinical segment, increasing awareness among the population, and high disposable income. The American Cancer Society, Inc. stated that 1.9 million new cancer cases were diagnosed and 609,360 cancer deaths in the US. Thus, this increasing patient pool will enhance market growth during the forecast period.
Further, the major countries will be study are US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: CELL CULTURE MEDIA MARKET BY REGION 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe cell culture suppliments market accounted for the second-largest market share due high disposable income per individual and increased healthcare spending. Furthermore, the Germany cell culture media provider attributed to hold the largest market share, and the France cell culture media providers is projected be the fastest growing market in the Europe region.
The Asia-Pacific cell culture media market is expected to be the fastest growing from 2024 to 2032 due to the presence of many research organizations, low manufacturing cost, low labor cost, developing healthcare infrastructure, and increased investments by the American and European market giants in Asian countries such as China and India are likely to drive the demand for cell culture media in the Asia-Pacific region. Moreover, China cell culture suppliments accounted to hold the largest market share, and the India cell culture media is projected to be the fastest growing market in the Asia-Pacific region.
Cell Culture Media Key Market Players & Competitive Insights
The Cell Culture Media Market has been continuously growing owing to factors such as strategic initiatives to boost pharmaceutical R&D, increasing incidences of chronic diseases, cell culture media associated product launch & investment for research and development for oncology, neurology, and immunology drugs. The market has been distinguished by the presence of numerous global, regional, and local players to meet their customers' demands. Moreover, market participants are implementing several business strategies to strengthen their position in the marketplace. They are investing heavily in R&D to diversify their cell culture media product portfolio and expand the cell culture media market.
Thermo Fisher Scientific Inc. (US) specializes in various biotechnology products such as analytical instruments, laboratory supply chain programmes and e-commerce, laboratory equipment, lab services, and specialty diagnostics. It helps its customers solve complex analytical challenges, accelerate life sciences research, improve patient diagnostics, deliver medicines to the market, and increase the productivity of the laboratory. It has five premier brands: Thermo Scientific, Applied Biosystems, Invitrogen, Unity Lab Services, and Fisher Scientific. It offers combination of purchasing convenience, innovative technologies, and comprehensive services. It provides a wide range of media, reagents, plastics, instruments, and equipment for cell culture.
It is distributing its products in the following countries: Argentina, Brazil, Canada, Chile, Mexico, the US, Australia, China, India, Japan, Malaysia, New Zealand, Singapore, South Korea, Austria, Belgium, Czech Republic, Denmark, France, Germany, Israel, Italy, Netherlands, Spain, the UAE, the UK, Sweden, and Switzerland, among others.
Moreover, In January 2022, Thermo Fisher Scientific, Inc. (US) acquired PeproTech (US) to broader cell culture applications, especially for use in cellular research models. This acquisition complemented Thermo Fisher’s cell culture media products and will persistently assist in offering integrated products associated with the cell culture media.
Key Companies in the cell culture media market includes.
- Thermo Fisher Scientific Inc. (US)
- Sartorius AG (Germany)
- Merck KGaA (Germany)
- Danaher Corporation (US)
- Lonza (Switzerland)
- Becton, Dickinson and Company (US)
- HiMedia Laboratories (India)
- Corning Incorporated (US)
- Promocell GmbH (Germany)
- Bio-Rad Laboratories, Inc. (US)
Cell Culture Media Industry Developments
March 2023:Sartorius AG (Germany) acquired Polyplus (France) in order to offer an innovative solution that will complement Sartorius cell culture media business and create lucrative growth opportunities.
August 2022:Thermo Fisher Scientific, Inc. (US) expanded its cell culture media manufacturing site in Grand Island, New York (US) in order to meet increasing demand for cell culture media. This expansion is helping meet the demand of its customer while also preparing for future growth and continuously improving its global customer experience.
January 2022:Thermo Fisher Scientific, Inc. (US) acquired PeproTech (US) to broaden cell culture applications, especially for use in cellular research models. This acquired complemented Thermo Fisher’s cell culture media products and will persistently assist in offering integrated products associated with the cell culture media.
November 2021:Merck KGaA (Germany) signed strategic agreement with GI Innovation (South Korea) to facilitate biomedicine development in Korea. Through the mutual agreement, Merck will support GI Innovation with technologies and services including CHOZN platform, cell culture media, and overall process consulting and technical support.
October 2019:Thermo Fisher Scientific, Inc. (US) introduced a cell culture medium that can remain stable at room temperature, provides greater flexibility, and requires less energy. Moreover, this product reduces Thermo Fisher’s carbon footprints and makes the world cleaner.
Cell Culture Media Segmentation
Cell Culture Media Product Type Outlook
-
MediaÂ-
Basal Media- Dulbecco's Modified Eagle Medium (DMEM)
- Minimum Essential Medium (MEM)
- Others
- Complex Media
- Serum-Free
- CHO
- Stem Cell
- Others
-
-
SupplementsÂ- Fetal Bovine Serum (FBS)
- Newborn Calf Serum
- Horse Serum
- Others
Cell Culture Media Application Outlook
- Regenerative MedicineÂ
-
Biopharmaceutical Production- Monoclonal Antibodies
- Vaccines
- Others
- Research
Cell Culture Media Cell Type Outlook
- Animal CellsÂ
- Plant CellsÂ
- Bacterial Cells
Cell Culture Media Regional Outlook
-
North America- US
- Canada
-
Europe- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
-
Asia-Pacific- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
-
Rest of the World- Middle East
- Africa
- Latin America
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
